It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Severe psychological trauma triggers genetic, biochemical and morphological changes in amygdala neurons, which underpin the development of stress-induced behavioural abnormalities, such as high levels of anxiety. miRNAs are small, non-coding RNA fragments that orchestrate complex neuronal responses by simultaneous transcriptional/translational repression of multiple target genes. Here we show that miR-483-5p in the amygdala of male mice counterbalances the structural, functional and behavioural consequences of stress to promote a reduction in anxiety-like behaviour. Upon stress, miR-483-5p is upregulated in the synaptic compartment of amygdala neurons and directly represses three stress-associated genes: Pgap2, Gpx3 and Macf1. Upregulation of miR-483-5p leads to selective contraction of distal parts of the dendritic arbour and conversion of immature filopodia into mature, mushroom-like dendritic spines. Consistent with its role in reducing the stress response, upregulation of miR-483-5p in the basolateral amygdala produces a reduction in anxiety-like behaviour. Stress-induced neuromorphological and behavioural effects of miR-483-5p can be recapitulated by shRNA mediated suppression of Pgap2 and prevented by simultaneous overexpression of miR-483-5p-resistant Pgap2. Our results demonstrate that miR-483-5p is sufficient to confer a reduction in anxiety-like behaviour and point to miR-483-5p-mediated repression of Pgap2 as a critical cellular event offsetting the functional and behavioural consequences of psychological stress.
The role of miRNAs in regulating brain stress response remains relatively unexplored. Here the authors show that miR-483-5p-mediated repression of Pgap2 in amygdala of male mice offsets the functional and behavioural consequences of stress.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 University of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024)
2 Alberta Health Services, Pharmacy Department, Calgary, Canada (GRID:grid.413574.0) (ISNI:0000 0001 0693 8815)
3 Polish Academy of Sciences, Department of Molecular Neuropharmacology, Institute of Pharmacology, Krakow, Poland (GRID:grid.413454.3) (ISNI:0000 0001 1958 0162)
4 UK Dementia Research Institute at Imperial College London, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); Imperial College London, Department of Brain Sciences, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
5 Medical University of Bialystok, Department of Clinical Laboratory Diagnostics, Bialystok, Poland (GRID:grid.48324.39) (ISNI:0000000122482838)
6 Polish Academy of Sciences, Nencki Institute of Experimental Biology, Warszawa, Poland (GRID:grid.413454.3) (ISNI:0000 0001 1958 0162)
7 University of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024); University of Bristol, School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603)